WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. In this day and age, where the importance of early diagnosis and treatment have been on the rise due to the aging population and globalization of illnesses, WELLS BIO pursues to be the world’s life-caring companion to all mankind.
STD-12 (Sexually Transmitted Diseases 12
The careGENETM STD-12 detection kit is an in-vitro diagnostic Real-Time PCR reagent for qualitative detection of STD 12 species in the vaginal swab and urine specimen. The careGENETM STD-12 detection kit aid to diagnose STDs in patients with symptoms of sexually transmitted infections.
12 high-risk STD genotypes:
Neisseria gonorrhea
Chlamydia trachomatis
Ureaplasma urealyticum
Mycoplasma genitalium
Treponema pallidum
Ureaplasma parvum
Mycoplasma hominis
Trichomonas vaginalis
Candida albicans
Gardnerella vaginalis
Herpes Simplex Virus 1
Herpes Simplex Virus 2
Features
Individual Target result
Separate Control for each target
High sensitivity and specificity
Uracil-DNA Glycosylase (UDG) system is adapted to prevent contamination
Turnaround time, less than 2 hours reaction time
Auto- Interpretation Software
Sample type: Swab and Urine
HPV detection kit
The careGENETM HPV detection kit-M is designed to detect 25 types of human papillomavirus types (HPV). In conjunction with qPCR, it can genotype 4 high-risk HPVs (16, 18, 31, and 59) and 3 low-risk HPVs (6, 53, and 61). It can collectively detect 10 other high-risk HPVs (HPV 33, 35, 39, 45, 51, 52, 56, 58, 66, and 68), and 8 other low-risk HPVs (HPV 11, 40, 43, 44, 54, 70, 73, and 81) from crude cervical scraping (Liquid based Cytology).